H.R. 4392 · 109th Congress
To provide for the importation of pharmaceutical products under a compulsory license as provided for under…
Full title
To provide for the importation of pharmaceutical products under a compulsory license as provided for under the World Trade Organization.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
AllenSponsor11 cosponsors · 10 D, 1 I
D
Brown
RG
D
Grijalva
BS
I
Sanders
JC
D
Conyers
PS
D
Stark
RE
D
Emanuel
DK
D
Kucinich
LE
D
Evans
EC
D
Case
PD
D
DeFazio
JN
D
Nadler0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Requires the U.S. Trade Representative to inform the General Council of the World Trade Organization (WTO) that the United States: (1) declares itself an eligible importing member for the purpose of being able to import pharmaceutical products pursuant to the Decision of the General Council of August 30, 2003, on "Implementation of paragraph six of the Doha…
What it does: CRS summary · Introduced in House · Nov 18, 2005
Requires the U.S. Trade Representative to inform the General Council of the World Trade Organization (WTO) that the United States: (1) declares itself an eligible importing member for the purpose of being able to import pharmaceutical products pursuant to the Decision of the General Council of August 30, 2003, on "Implementation of paragraph six of the Doha Declaration on the TRIPS Agreement and public health;" and (2) withdraws its name from the list contained in the "General Council Chairperson's Statement" accompanying such Decision, of countries that voluntarily relinquished the right to import pharmaceutical products manufactured under compulsory licenses.
Authorizes the President to import pharmaceutical products manufactured under a compulsory license to meet public health needs or to address situations of inadequate supply caused by insufficient domestic manufacturing capacity, in accordance with the Decision. Subjects such imported pharmaceutical products to the Federal Food, Drug, and Cosmetic Act.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: To provide for the importation of pharmaceutical products under a compulsory license as provided for under the World Trade Organization.
Latest action (Nov 18, 2005): Referred to the House Committee on Ways and Means.
Policy area: Foreign Trade and International Finance · Origin: House · Introduced: Nov 18, 2005
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.